₹46
*Average Price as per 30 January, 2026

Fundamentals
FACE VALUE
10
BOOK VALUE
42.22
NO OF SHARES
100000000
EPS
3.91
SALES
407.52
INDUSTRY PE
60
DIVIDEND
0
DIVIDEND YIELD
0
PE
27.88
PB
2.58
PS
2.67
MARKET CAP
1090
EQUITY
100
PAT
39.01
MESSAGE
2024-25
OVERVIEW
INSIGHT
| ₹ crore | FY25 | FY24 | YoY Growth |
|---|---|---|---|
| Revenue | 407.52 | 396.22 | +2.9% |
| EBITDA | 70.89 | 72.96 | -2.8% |
| PAT | 39.12 | 43.87 | -10.8% |
Summary:
FY25 saw steady topline growth, but profitability moderated due to higher operating costs, depreciation, and tax expenses, resulting in margin compression at the EBITDA and PAT level
Lakeshore Hospitals operates in India’s organised hospital and healthcare services sector, a structurally growing and largely non-cyclical industry.
Demand-led growth: Driven by rising lifestyle diseases, ageing demographics, higher healthcare awareness, and increasing insurance coverage.
Shift to organised care: Patients increasingly prefer accredited, multi-specialty hospitals with advanced clinical capabilities.
Cost structure dynamics: Margins are sensitive to manpower costs, consumables, energy expenses, and depreciation from continuous capex.
Medical tourism: India continues to attract international patients for complex procedures at competitive costs.
Long-term outlook: Stable, long-duration growth with near-term performance linked to occupancy levels, case-mix optimisation, and operating efficiency.
SECONDARY NAME
ISIN
CDSL
NSDL
INDUSTRY
SECTOR (READ ONLY)
SHARE HOLDINGS
| Name of Shareholder | Holdings |
|---|---|
| Dr. Shamsheer Vayalil Parambath | 0.43 % |
| Mr. Yusuff Ali M A | 0.19 % |
| Others | 38.58 % |
We're different. SB NRI is the first of it's kind platform built for NRIs offering digital Investment plans.
Schedule a CallTrusted by 1,000s of NRIs spread across the Globe